← Back
Data updated: Mar 10, 2026
FALCON PHARMS
Immunology
FALCON PHARMS is a pharmaceutical company focused on Immunology.
1994
Since
2
Drugs
-
Trials
57
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DICLOFENAC SODIUM 2025-12-31
Labeling
DICLOFENAC SODIUM 2025-11-05
DICLOFENAC SODIUM 2025-09-26
Labeling
DICLOFENAC SODIUM 2025-05-21
Labeling
DICLOFENAC SODIUM 2025-04-09
DICLOFENAC SODIUM 2024-11-21
Labeling
DICLOFENAC SODIUM 2024-11-21
Labeling
DICLOFENAC SODIUM 2024-11-21
Labeling
DICLOFENAC SODIUM 2024-11-21
Labeling
DICLOFENAC SODIUM 2024-11-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- 1994-06-30
- Latest
- 2002-10-01
- Applications
- 2